Vir Biotechnology VIR
NASDAQ VIR
$10.64 -0.01 (-0.09%)
As of: Sep 30, 2026 · 9:33 AM EDT

Vir Biotechnology (VIR) EV to EBITDA (2021 - 2022)

Updated

Vir Biotechnology's EV to EBITDA came in at 1.19 for Q4 2022, down 89.7% from 11.55 a year earlier but up 672.4% from the prior quarter.

Analysis

Vir Biotechnology (VIR) EV to EBITDA (2021 - 2022) Analysis & Trends

Going back to Q4 2021, Vir Biotechnology's EV to EBITDA data covers 5 quarters.

  • Going back by year, EV to EBITDA was 11.55 in FY2021.
  • The five-year range for quarterly EV to EBITDA is 0.15 (Q3 2022) to 11.55 (Q4 2021).
  • Business Quant data shows VIR's EV to EBITDA at 0.15 (Q3 2022), 0.93 (Q2 2022) and 1.37 (Q1 2022) in the three quarters before Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Vir Biotechnology 1.78 Bn 1.78 Bn 238.95 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 1.19
Sep 30, 2022 0.15
Jun 30, 2022 0.93
Mar 31, 2022 1.37
Dec 31, 2021 11.55
API Access

Vir Biotechnology EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=VIR&period=max&api_key=YOUR_API_KEY